In its opening months, after spinning off as a separate business from Novartis, Sandoz is riding the wave of a strong launch of its biosimilar version of AbbVie’s Humira (adalimumab). | After spinning ...
2-Year U.S. Treasury Note Continuous Contract $101.738 0.012 0.01% 5-Year U.S. Treasury Note Continuous Contract $105.766 0.031 0.03% 10-Year U.S. Treasury Note Continuous Contract $108.969 0.078 ...